BofA Remains Neutral on Bristol-Myers Squibb Company (BMY), Expects Low Single-Digit Growth in the Long Term

By Faheem Tahir | November 10, 2025, 8:16 PM
Bristol-Myers Squibb Company (NYSE:BMY) is included in our list of the 12 deep value stocks to invest in.
BofA Remains Neutral on Bristol-Myers Squibb Company (BMY), Expects Low Single-Digit Growth in the Long Term
A dose bottle of the medication is in the medical tech's hand On November 3, 2025, BofA raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) from $50 to $52, reiterating its “Neutral” rating. The investment firm revised its 2026 revenue forecast upward 1.5% and EPS forecast upward 1% following the company’s Q3 results. Despite the company’s strong quarterly performance, BofA expects only low single-digit growth in the long term. Meanwhile, on October 31, BMO Capital’s Evan Seigerman also maintained his “Hold” rating on Bristol-Myers Squibb Company (NYSE:BMY) with a $47 price target. The analyst cited the company’s mixed short-term outlook, marked by strong demand for Camzyos and Breyanzi offset by the slower rollout of Cobenfy. He also highlighted concerns about patent expirations and the competitive pressures they create. The company’s October 30 earnings report preceded both of these updates, in which Bristol-Myers Squibb Company (NYSE:BMY) reported $12.2 billion in quarterly revenue, up 3%, thanks to 18% growth from its expanding Growth portfolio. The quarter also marked an increase in the company’s full-year guidance and the acquisition of Orbital Therapeutics. The acquisition reflects the company’s focus on next-generation RNA and cell therapies. The company reported GAAP EPS of $1.08. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that protect patients against serious diseases. While we acknowledge the potential of BMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential. Disclosure: None.

Mentioned In This Article

Latest News

Nov-10
Nov-10
Nov-07
Nov-07
Nov-06
Nov-06
Nov-05
Nov-05
Nov-05
Nov-03
Nov-03
Nov-03
Oct-31
Oct-30
Oct-30